{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T22:33:08Z","timestamp":1785018788162,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T00:00:00Z","timestamp":1261612800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s10549-009-0685-6","type":"journal-article","created":{"date-parts":[[2009,12,23]],"date-time":"2009-12-23T11:07:16Z","timestamp":1261566436000},"page":"119-126","source":"Crossref","is-referenced-by-count":87,"title":["Is the breast-conserving treatment with radiotherapy appropriate in BRCA1\/2 mutation carriers? Long-term results and review of the literature"],"prefix":"10.1007","volume":"120","author":[{"given":"Youlia M.","family":"Kirova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Savignoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Sigal-Zafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"de La Rochefordiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my J.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"This","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Asselain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Stoppa-Lyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fourquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,24]]},"reference":[{"key":"685_CR1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/107327480200900602","volume":"9","author":"ME Robson","year":"2002","unstructured":"Robson ME (2002) Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer. Cancer Control 9:457\u2013465","journal-title":"Cancer Control"},{"key":"685_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.11048","volume":"97","author":"C Adem","year":"2003","unstructured":"Adem C, Reynolds C, Soderberg CL et al (2003) Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer 97:1\u201311","journal-title":"Cancer"},{"key":"685_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.0.CO;2-5","volume":"18","author":"PO Chappuis","year":"2000","unstructured":"Chappuis PO, Nethercot V, Foules WD et al (2000) Clinico-pathological characteristics of BRCA1 and BRCA2-related breast cancer. Semin Surg Oncol 18:287\u2013295","journal-title":"Semin Surg Oncol"},{"key":"685_CR4","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1200\/JCO.2000.18.24.4053","volume":"18","author":"D Stoppa-Lyonnet","year":"2000","unstructured":"Stoppa-Lyonnet D, Ansquer Y, Dreyfus H et al (2000) Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol 18:4053\u20134059","journal-title":"J Clin Oncol"},{"key":"685_CR5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1008340723974","volume":"11","author":"WD Foulkes","year":"2000","unstructured":"Foulkes WD, Chappuis PO, Wong N et al (2000) Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome. Ann Oncol 11:307\u2013313","journal-title":"Ann Oncol"},{"key":"685_CR6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","volume":"351","author":"LC Verhoog","year":"1998","unstructured":"Verhoog LC, Brekelmans CTM, Seynaeve C et al (1998) Survival and tumour characteristics of breast cancer patients with germline mutations of BRCA1. Lancet 351:316\u2013321","journal-title":"Lancet"},{"key":"685_CR7","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","volume":"349","author":"Breast Cancer Linkage Consortium","year":"1997","unstructured":"Breast Cancer Linkage Consortium (1997) Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349:1505\u20131510","journal-title":"Lancet"},{"key":"685_CR8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","volume":"90","author":"SR Lakhani","year":"1998","unstructured":"Lakhani SR, Jacquemier J, Sloane JP et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90:1138\u20131145","journal-title":"J Natl Cancer Inst"},{"key":"685_CR9","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/bcr658","volume":"6","author":"M Robson","year":"2004","unstructured":"Robson M, Chappuis PO, Satagopan J et al (2004) A combined analysis of outcome following breast cancer: differences in survival based on BRCA1\/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res 6:R8\u2013R17","journal-title":"Breast Cancer Res"},{"key":"685_CR10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","volume":"108","author":"A Venkitaraman","year":"2002","unstructured":"Venkitaraman A (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171\u2013182","journal-title":"Cell"},{"key":"685_CR11","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1038\/sj.onc.1206678","volume":"22","author":"SN Powel","year":"2003","unstructured":"Powel SN, Kachnic LA (2003) Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionising radiation. Oncogene 22:5784\u20135791","journal-title":"Oncogene"},{"key":"685_CR12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/sj.bjc.6600628","volume":"87","author":"A Baeyens","year":"2002","unstructured":"Baeyens A, Thierens H, Claes K et al (2002) Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87:1379\u20131385","journal-title":"Br J Cancer"},{"key":"685_CR13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1054\/bjoc.2000.1438","volume":"83","author":"P Freneaux","year":"2000","unstructured":"Freneaux P, Stoppa-Lyonnet D, Mouret E et al (2000) Low expression of bcl-2 in Brca1-associated breast cancers. Br J Cancer 83:1318\u20131322","journal-title":"Br J Cancer"},{"key":"685_CR14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200102223440801","volume":"344","author":"I Hedenfalk","year":"2001","unstructured":"Hedenfalk I, Duggan D, Chen Y et al (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344:539\u2013548","journal-title":"N Engl J Med"},{"key":"685_CR15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1126\/science.286.5442.1162","volume":"286","author":"D Cortez","year":"1999","unstructured":"Cortez D, Wang Y, Qin J et al (1999) Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks. Science 286:1162\u20131166","journal-title":"Science"},{"key":"685_CR16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0092-8674(00)80503-6","volume":"90","author":"R Scully","year":"1997","unstructured":"Scully R, Chen J, Ochs RL et al (1997) Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90:425\u2013435","journal-title":"Cell"},{"key":"685_CR17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1097-2765(00)80466-9","volume":"3","author":"X Xu","year":"1999","unstructured":"Xu X, Weaver Z, Linke SP et al (1999) Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 3:389\u2013395","journal-title":"Mol Cell"},{"key":"685_CR18","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1038\/sj.onc.1204929","volume":"20","author":"SG Brodie","year":"2000","unstructured":"Brodie SG, Xu X, Qiao W et al (2000) Multiple genetic changes are associated with mammary tumorigenesis in BRCA1 conditional knockout mice. Oncogene 20:7514\u20137523","journal-title":"Oncogene"},{"key":"685_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/COC.0b013e31817f9e1c","volume":"32","author":"A Fourquet","year":"2009","unstructured":"Fourquet A, Stoppa-Lyonnet D, Sigal-Zafrani B et al (2009) Familial invasive breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1 and BRCA2 mutations. Am J Clin Oncol 32:127\u2013131","journal-title":"Am J Clin Oncol"},{"key":"685_CR20","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233\u20131241","journal-title":"N Engl J Med"},{"key":"685_CR21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/jnci\/84.9.683","volume":"84","author":"R Clark","year":"1992","unstructured":"Clark R, McCullock P, Levine M et al (1992) Randomised clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84:683\u2013689","journal-title":"J Natl Cancer Inst"},{"key":"685_CR22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/92.14.1143","volume":"92","author":"JA Dongen Van","year":"2000","unstructured":"Van Dongen JA, Voogd AC, Fentiman IS et al (2000) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: EORTC 10801 trial. J Natl Cancer Inst 92:1143\u20131150","journal-title":"J Natl Cancer Inst"},{"key":"685_CR23","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","volume":"347","author":"U Veronesi","year":"2002","unstructured":"Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomised study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227\u20131232","journal-title":"N Engl J Med"},{"key":"685_CR24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM199504063321402","volume":"332","author":"JA Jacobson","year":"1995","unstructured":"Jacobson JA, Danforth DN, Cowan KH et al (1995) Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332:907\u2013911","journal-title":"N Engl J Med"},{"key":"685_CR25","first-page":"19","volume":"11","author":"M Blichert-Toft","year":"1992","unstructured":"Blichert-Toft M, Roce C, Anderson JA et al (1992) Danish randomised trial comparing breast conservation therapy with mastectomy: six years of life table analysis. Danish Breast Cancer Cooperative group. J Natl Cancer Inst Monograms 11:19\u201325","journal-title":"J Natl Cancer Inst Monograms"},{"key":"685_CR26","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/annonc\/mdg452","volume":"14","author":"R Arriagada","year":"2003","unstructured":"Arriagada R, Le MG, Guinebreti\u00e8re JM et al (2003) Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 14:1617\u20131622","journal-title":"Ann Oncol"},{"key":"685_CR27","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087\u20132106","journal-title":"Lancet"},{"key":"685_CR28","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.ejca.2005.02.037","volume":"41","author":"YM Kirova","year":"2005","unstructured":"Kirova YM, Stoppa-Lyonnet D, Savignoni A et al (2005) Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Eur J Cancer 41:2304\u20132311","journal-title":"Eur J Cancer"},{"key":"685_CR29","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2000.18.19.3360","volume":"18","author":"LJ Pierce","year":"2000","unstructured":"Pierce LJ, Strawderman M, Narod SA et al (2000) Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1\/2 mutations. J Clin Oncol 18:3360\u20133369","journal-title":"J Clin Oncol"},{"key":"685_CR30","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2005.02.7888","volume":"24","author":"L Pierce","year":"2006","unstructured":"Pierce L, Levin A, Rebbeck T et al (2006) Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1\/2-associated stage I\/II breast cancer. J Clin Oncol 24:2437\u20132443","journal-title":"J Clin Oncol"},{"issue":"5","key":"685_CR31","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ejca.2006.12.009","volume":"43","author":"CT Brekelmans","year":"2007","unstructured":"Brekelmans CT, Tilanus-Linthorst MM, Seynaeve C et al (2007) Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1\/2 families as compared to sporadic breast cancer cases. Eur J Cancer 43(5):867\u2013876","journal-title":"Eur J Cancer"},{"key":"685_CR32","unstructured":"Delaloge S, Kloos I, Ariane D et al (2003) Young age is the major predictor of local relapse among conservatively treated BRCA1-, BRCA2-, or non BRCA-linked hereditary breast cancer. ASCO Proc 22(abstr 41):11"},{"key":"685_CR33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.bjc.6604241","volume":"98","author":"YM Kirova","year":"2008","unstructured":"Kirova YM, De Rycke Y, Gambotti L et al (2008) Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer 98:870\u2013874","journal-title":"Br J Cancer"},{"key":"685_CR34","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/cncr.21223","volume":"104","author":"Y Kirova","year":"2005","unstructured":"Kirova Y, Vilcoq JR, Asselain B et al (2005) Radiation-induced sarcomas (RIS) following radiotherapy for breast cancer: a large-scale single institution review. Cancer 104:856\u2013863","journal-title":"Cancer"},{"key":"685_CR35","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton DF (2002) The breast cancer linkage consortium: cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358\u20131365","journal-title":"J Natl Cancer Inst"},{"key":"685_CR36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3844\/ajisp.2006.61.63","volume":"2","author":"YM Kirova","year":"2006","unstructured":"Kirova YM, Fourquet A, Savignoni A et al (2006) Risk of second non breast malignancies (SNBM) in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Am J Immunol 2:61\u201363","journal-title":"Am J Immunol"},{"key":"685_CR37","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","volume":"359","author":"BG Haffty","year":"2002","unstructured":"Haffty BG, Harrold E, Khan AJ et al (2002) Outcome of conservatively managed early-onset breast cancer by BRCA1\/BRCA2 status. Lancet 359:1471\u20131477","journal-title":"Lancet"},{"key":"685_CR38","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ejca.2004.01.017","volume":"40","author":"C Seynaeve","year":"2004","unstructured":"Seynaeve C, Verhoog LC, Van De Bosch LM et al (2004) Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. Eur J Cancer 40:1150\u20131158","journal-title":"Eur J Cancer"},{"key":"685_CR39","unstructured":"Bremer M, Doerk T, Sohn C et al (2003): Local relapse after postoperative radiotherapy in patients with bilateral breast cancer by BRCA1\/2 status. ASCO Proc 22(abstr 42):11"},{"key":"685_CR40","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1200\/JCO.1999.17.10.3017","volume":"17","author":"BC Turner","year":"1999","unstructured":"Turner BC, Harrold E, Matloff E et al (1999) BRCA1\/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1\/BRCA2 mutations. J Clin Oncol 17:3017\u20133024","journal-title":"J Clin Oncol"},{"key":"685_CR41","doi-asserted-by":"crossref","unstructured":"Garcia-Etienne CA, Barile M, Gentilini OD et al (2009) Breast-conserving surgery in BRCA1\/2 mutation carriers: are we approaching an answer? Ann Surg Oncol (in press)","DOI":"10.1245\/s10434-009-0638-7"},{"key":"685_CR42","first-page":"1021","volume":"60","author":"D Stoppa-Lyonnet","year":"1997","unstructured":"Stoppa-Lyonnet D, Laurent-Puig P, Essioux L et al (1997) BRCA1 sequence variations in 160 individuals referred to a breast\/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet 60:1021\u20131030","journal-title":"Am J Hum Genet"},{"key":"685_CR43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/geno.1999.6026","volume":"62","author":"T Wagner","year":"1999","unstructured":"Wagner T, Stoppa-Lyonnet D, Fleischmann E et al (1999) Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 62:369\u2013376","journal-title":"Genomics"},{"key":"685_CR44","first-page":"232","volume":"48","author":"EB Claus","year":"1991","unstructured":"Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232\u2013242","journal-title":"Am J Hum Genet"},{"key":"685_CR45","first-page":"678","volume":"52","author":"DF Easton","year":"1993","unstructured":"Easton DF, Bishop DT, Ford D et al (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52:678\u2013701","journal-title":"Am J Hum Genet"},{"key":"685_CR46","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0960-9776(97)90574-9","volume":"6","author":"RJ Salmon","year":"1997","unstructured":"Salmon RJ, Asselain B, Le Gal M et al (1997) Twelve years experience of breast cancer at the Institut Curie: improvement of survival and value of screening mammographics. Breast 6:202\u2013205","journal-title":"Breast"},{"key":"685_CR47","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2006.05.014","volume":"79","author":"Y Kirova","year":"2006","unstructured":"Kirova Y, Servois V, Campana F et al (2006) CT- scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning. Radiother Oncol 79:310\u2013315","journal-title":"Radiother Oncol"},{"key":"685_CR48","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ijrobp.2004.08.051","volume":"61","author":"F Campana","year":"2005","unstructured":"Campana F, Kirova YM, Rosenwald JC et al (2005) Breast radiotherapy in the lateral decubitus position\u2013a technique to prevent lung and heart irradiation. Int J Radiat Oncol Biol Phys 61:1348\u20131354","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"685_CR49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijrobp.2007.12.059","volume":"72","author":"YM Kirova","year":"2008","unstructured":"Kirova YM, Fournier-Bidoz N, Servois V et al (2008) How to boost the breast tumor bed? A multidisciplinary approach in 8 steps. Int J Radiat Oncol Biol Phys 72:494\u2013500","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"685_CR50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"685_CR51","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163\u2013170","journal-title":"Cancer Chemother Rep"},{"key":"685_CR52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life tables. J R Stat Soc 34:187\u2013220","journal-title":"J R Stat Soc"},{"key":"685_CR53","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","volume":"356","author":"SA Narod","year":"2000","unstructured":"Narod SA, Brunet JS, Ghadirian P et al (2000) Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case\u2013control study. Lancet 356:1876\u20131881","journal-title":"Lancet"},{"key":"685_CR54","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/srao.2002.35254","volume":"12","author":"L Pierce","year":"2002","unstructured":"Pierce L (2002) Radiotherapy for breast cancer in BRCA1\/BRCA2 carriers: clinical issues and management dilemmas. Semin Radiat Oncol 12:352\u2013361","journal-title":"Semin Radiat Oncol"},{"key":"685_CR55","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(00)02347-3","volume":"355","author":"EJ Meijers-Heijboer","year":"2000","unstructured":"Meijers-Heijboer EJ, Verhoog LC, Brekelmans CTM et al (2000) Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355:2015\u20132020","journal-title":"Lancet"},{"key":"685_CR56","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1200\/JCO.2008.21.0518","volume":"27","author":"A Reicht","year":"2009","unstructured":"Reicht A (2009) Contralateral prophylactic mastectomy: caveat emptor. J Clin Oncol 27:1347\u20131349","journal-title":"J Clin Oncol"},{"key":"685_CR57","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1196\/annals.1414.020","volume":"1138","author":"Y Drew","year":"2008","unstructured":"Drew Y, Calvert H (2008) The potential of PARP inhibitors in genetic breast and ovarian cancers. Ann N Y Acad Sci 1138:136\u2013145","journal-title":"Ann N Y Acad Sci"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0685-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0685-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0685-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T21:36:37Z","timestamp":1739655397000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0685-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,24]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0685-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,24]]}}}